A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images - Trial NCT06421844
Access comprehensive clinical trial information for NCT06421844 through Pure Global AI's free database. This phase not specified trial is sponsored by Air Force Military Medical University, China and is currently Recruiting. The study focuses on Jaundice,Deep Learning,Hyperbilirubinemia,Sclera. Target enrollment is 270 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Air Force Military Medical University, China
Timeline & Enrollment
N/A
Apr 20, 2024
Jul 10, 2024
Primary Outcome
Loss of predicted bilirubin levels,Classification accuracy
Summary
The primary efficacy endpoints are the standard deviation and coefficient of determination
 (R2) between predicted and actual values for the bilirubin regression model, and the grading
 accuracy for the jaundice severity classification model. The secondary efficacy endpoint is
 the mean percentage error between predicted and actual bilirubin values. There are no
 relevant safety risks.
 
 Statistical differences for categorical variables (e.g., jaundice grading evaluation
 indicators) will be analyzed using the chi-square test or Fisher's exact probability test.
 For continuous variables (e.g., bilirubin prediction evaluation indicators), t-tests (normal
 distribution) or non-parametric tests (non-normal distribution) will be used. The 95%
 confidence interval for jaundice grading accuracy will be calculated using the Wilson method.
 
 The study duration is estimated to be 3 months.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06421844
Non-Device Trial